F. Hanefeld

761 total citations
22 papers, 547 citations indexed

About

F. Hanefeld is a scholar working on Molecular Biology, Neurology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, F. Hanefeld has authored 22 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Neurology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in F. Hanefeld's work include Metabolism and Genetic Disorders (3 papers), Neurological and metabolic disorders (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). F. Hanefeld is often cited by papers focused on Metabolism and Genetic Disorders (3 papers), Neurological and metabolic disorders (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). F. Hanefeld collaborates with scholars based in Germany, Sweden and Poland. F. Hanefeld's co-authors include Kevin Rostásy, M. Lehnert, Bernd Krone, Elke Kahler, Jutta Gärtner, Daniela Pohl, Hans‐Joachim Wagner, Edgar Brunner, B. Wilken and Helena Stibler and has published in prestigious journals such as Neurology, Radiology and Developmental Medicine & Child Neurology.

In The Last Decade

F. Hanefeld

21 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Hanefeld Germany 11 152 149 141 77 72 22 547
A. R. Massaro Italy 12 171 1.1× 248 1.7× 192 1.4× 53 0.7× 86 1.2× 22 532
Jean‐Michel Pédespan France 9 104 0.7× 134 0.9× 89 0.6× 35 0.5× 33 0.5× 14 494
G V McDonnell United Kingdom 12 444 2.9× 66 0.4× 183 1.3× 74 1.0× 78 1.1× 24 663
R O McKeran United Kingdom 17 89 0.6× 430 2.9× 101 0.7× 39 0.5× 21 0.3× 30 844
Y. Goldhammer Israel 16 218 1.4× 132 0.9× 549 3.9× 33 0.4× 66 0.9× 37 986
Isabelle Korn‐Lubetzki Israel 11 91 0.6× 52 0.3× 162 1.1× 26 0.3× 72 1.0× 35 472
Rabab Debs France 12 72 0.5× 114 0.8× 237 1.7× 39 0.5× 41 0.6× 25 486
Johann te Water Naudé United Kingdom 8 160 1.1× 172 1.2× 119 0.8× 19 0.2× 30 0.4× 17 417
A. Hori Germany 15 70 0.5× 158 1.1× 125 0.9× 12 0.2× 35 0.5× 50 766
Michael Karenfort Germany 13 493 3.2× 86 0.6× 430 3.0× 107 1.4× 47 0.7× 32 828

Countries citing papers authored by F. Hanefeld

Since Specialization
Citations

This map shows the geographic impact of F. Hanefeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Hanefeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Hanefeld more than expected).

Fields of papers citing papers by F. Hanefeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Hanefeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Hanefeld. The network helps show where F. Hanefeld may publish in the future.

Co-authorship network of co-authors of F. Hanefeld

This figure shows the co-authorship network connecting the top 25 collaborators of F. Hanefeld. A scholar is included among the top collaborators of F. Hanefeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Hanefeld. F. Hanefeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilken, B., Marc Baumann, Christian G. Bien, et al.. (2007). Chronic relapsing opsoclonus-myoclonus syndrome: Combination of cyclophosphamide and dexamethasone pulses. European Journal of Paediatric Neurology. 12(1). 51–55. 34 indexed citations
2.
Pohl, Daniela, Bernd Krone, Kevin Rostásy, et al.. (2006). High seroprevalence of Epstein–Barr virus in children with multiple sclerosis. Neurology. 67(11). 2063–2065. 169 indexed citations
3.
Pohl, Daniela, et al.. (2005). Association of Epstein-Barr virus (EBV) infection with multiple sclerosis in pediatric patients. Neuropediatrics. 36(2). 1 indexed citations
4.
Ellies, Maik, Saskia Rohrbach‐Volland, C. Arglebe, et al.. (2003). Successful Management of Drooling with Botulinum Toxin A in Neurologically Disabled Children. Neuropediatrics. 33(6). 327–330. 50 indexed citations
5.
Wilken, B., Peter Dechent, Knut Brockmann, et al.. (2003). Quantitative Proton Magnetic Resonance Spectroscopy of Children with Adrenoleukodystrophy Before and After Hematopoietic Stem Cell Transplantation. Neuropediatrics. 34(5). 237–246. 28 indexed citations
6.
Huppke, Peter, et al.. (2002). Altered Methylation Pattern of the G6 PD Promoter in Rett Syndrome. Neuropediatrics. 33(2). 105–108. 9 indexed citations
7.
Christen, H.‐J., et al.. (2000). Foix–Chavany–Marie (anterior operculum) syndrome in childhood: a reappraisal of Worster-Drought syndrome. Developmental Medicine & Child Neurology. 42(2). 122–132. 48 indexed citations
8.
Huppke, Peter, et al.. (2000). Two brothers with Hennekam syndrome and cerebral abnormalities. Clinical Dysmorphology. 9(1). 21–24. 11 indexed citations
9.
Hanefeld, F., et al.. (2000). Foix‐Chavany‐Marie (anterior operculum) syndrome in childhood: a reappraisal of Worster‐Drought syndrome. Developmental Medicine & Child Neurology. 42(2). 122–132. 16 indexed citations
10.
Pouwels, Petra J. W., B. Kruse, Georg Christoph Korenke, et al.. (1998). Quantitative Proton Magnetic Resonance Spectroscopy of Childhood Adrenoleukodystrophy. Neuropediatrics. 29(5). 254–264. 68 indexed citations
11.
Korenke, GC, H.‐J. Christen, D. H. Hunneman, & F. Hanefeld. (1996). Failure of beta interferon therapy in X-linked adrenoleukodystrophy. European Journal of Pediatrics. 155(9). 833–833. 1 indexed citations
12.
Midro, Alina T., et al.. (1996). [Jaeken's (CDG) syndrome in two sisters].. PubMed. 71(7). 621–8. 3 indexed citations
13.
Christen, H.‐J., Helmut Eiffert, Andreas Ohlenbusch, & F. Hanefeld. (1995). Evaluation of the polymerase chain reaction for the detection of Borrelia burgdorferi in cerebrospinal fluid of children with acute peripheral facial palsy. European Journal of Pediatrics. 154(5). 374–377. 1 indexed citations
14.
Stibler, Helena, et al.. (1993). Carbohydrate-Deficient Glycoprotein (CDG) Syndrome - A New Variant, Type III. Neuropediatrics. 24(1). 51–52. 60 indexed citations
15.
Hanefeld, F., et al.. (1990). Akute Chorea nach Herzoperation in Hypothermie und totalem Bypass. Klinische Pädiatrie. 202(2). 115–116. 1 indexed citations
16.
17.
Hampl, H., et al.. (1983). Electroencephalogram investigations of the disequilibrium syndrome during bicarbonate and acetate dialysis.. PubMed. 19. 351–9. 7 indexed citations
18.
Schiller, R., et al.. (1982). Advantages of Bicarbonate Hemodialysis. Artificial Organs. 6(4). 410–416. 13 indexed citations
19.
Schrøder, Henrik Daa, et al.. (1982). [Long-term sequelae of neonatal group B streptococcal septicemia/meningitis (author's transl)].. PubMed. 130(3). 153–6. 1 indexed citations
20.
Siemes, H., et al.. (1979). [Three sisters with encephalitis in a family with Bloch-Sulzberger syndrome. Possible significance of infectious processes for pathogenesis of CNS involvement].. PubMed. 127(5). 321–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026